These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 28866946)

  • 1. Bridging a Patient with Acute Liver Failure to Liver Transplantation by the AMC-Bioartificial Liver.
    Van De Kerkhove MP; Di Florio E; Scuderi V; Mancini A; Belli A; Bracco A; Scala D; Scala S; Zeuli L; Di Nicuolo G; Amoroso P; Calise F; Chamuleau RAFM
    Cell Transplant; 2003 Sep; 12(6):563-568. PubMed ID: 28866946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging a patient with acute liver failure to liver transplantation by the AMC-bioartificial liver.
    van de Kerkhove MP; Di Florio E; Scuderi V; Mancini A; Belli A; Bracco A; Scala D; Scala S; Zeuli L; Di Nicuolo G; Amoroso P; Calise F; Chamuleau RA
    Cell Transplant; 2003; 12(6):563-8. PubMed ID: 14579924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence of in vitro and in vivo porcine endogenous retrovirus infection after plasmapheresis through the AMC-bioartificial liver.
    Di Nicuolo G; van de Kerkhove MP; Hoekstra R; Beld MG; Amoroso P; Battisti S; Starace M; di Florio E; Scuderi V; Scala S; Bracco A; Mancini A; Chamuleau RA; Calise F
    Xenotransplantation; 2005 Jul; 12(4):286-92. PubMed ID: 15943777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I clinical trial with the AMC-bioartificial liver.
    van de Kerkhove MP; Di Florio E; Scuderi V; Mancini A; Belli A; Bracco A; Dauri M; Tisone G; Di Nicuolo G; Amoroso P; Spadari A; Lombardi G; Hoekstra R; Calise F; Chamuleau RA
    Int J Artif Organs; 2002 Oct; 25(10):950-9. PubMed ID: 12456036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver support therapy: an overview of the AMC-bioartificial liver research.
    van de Kerkhove MP; Poyck PP; Deurholt T; Hoekstra R; Chamuleau RA; van Gulik TM
    Dig Surg; 2005; 22(4):254-64. PubMed ID: 16174982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioartificial liver support systems for acute liver failure: A systematic review and meta-analysis of the clinical and preclinical literature.
    He YT; Qi YN; Zhang BQ; Li JB; Bao J
    World J Gastroenterol; 2019 Jul; 25(27):3634-3648. PubMed ID: 31367162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients.
    Morsiani E; Pazzi P; Puviani AC; Brogli M; Valieri L; Gorini P; Scoletta P; Marangoni E; Ragazzi R; Azzena G; Frazzoli E; Di Luca D; Cassai E; Lombardi G; Cavallari A; Faenza S; Pasetto A; Girardis M; Jovine E; Pinna AD
    Int J Artif Organs; 2002 Mar; 25(3):192-202. PubMed ID: 11999191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acute-liver-failure-plasma exposure on hepatic functionality of HepaRG-AMC-bioartificial liver.
    Nibourg GA; Hoekstra R; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Chamuleau RA
    Liver Int; 2013 Apr; 33(4):516-24. PubMed ID: 23387413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for Galalpha(1-3)Gal expression on primary porcine hepatocytes: implications for bioartificial liver systems.
    van de Kerkhove MP; Germans MR; Deurholt T; Hoekstra R; Joziasse DH; van Wijk AC; van Gulik TM; Chamuleau RA; Roos A
    J Hepatol; 2005 Apr; 42(4):541-7. PubMed ID: 15763340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells.
    Frühauf JH; Mertsching H; Giri S; Frühauf NR; Bader A
    Liver Int; 2009 Nov; 29(10):1553-61. PubMed ID: 19686312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of bioartificial liver support systems.
    van de Kerkhove MP; Hoekstra R; Chamuleau RA; van Gulik TM
    Ann Surg; 2004 Aug; 240(2):216-30. PubMed ID: 15273544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of human fulminant hepatic failure sera on endogenous retroviral expression in pig hepatocytes.
    Nyberg SL; Hibbs JR; Hardin JA; Germer JJ; Platt JL; Paya CV; Wiesner RH
    Liver Transpl; 2000 Jan; 6(1):76-84. PubMed ID: 10648582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in cell sources of hepatocytes for bioartificial liver.
    Pan XP; Li LJ
    Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):594-605. PubMed ID: 23232630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe liver failure with a bioartificial liver.
    Chen SC; Mullon C; Kahaku E; Watanabe F; Hewitt W; Eguchi S; Middleton Y; Arkadopoulos N; Rozga J; Solomon B; Demetriou AA
    Ann N Y Acad Sci; 1997 Dec; 831():350-60. PubMed ID: 9616727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term absence of porcine endogenous retrovirus infection in chronically immunosuppressed patients after treatment with the porcine cell-based Academic Medical Center bioartificial liver.
    Di Nicuolo G; D'Alessandro A; Andria B; Scuderi V; Scognamiglio M; Tammaro A; Mancini A; Cozzolino S; Di Florio E; Bracco A; Calise F; Chamuleau RA
    Xenotransplantation; 2010; 17(6):431-9. PubMed ID: 21158944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes.
    Shi XL; Gao Y; Yan Y; Ma H; Sun L; Huang P; Ni X; Zhang L; Zhao X; Ren H; Hu D; Zhou Y; Tian F; Ji Y; Cheng X; Pan G; Ding YT; Hui L
    Cell Res; 2016 Feb; 26(2):206-16. PubMed ID: 26768767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auxiliary liver transplantation and bioartificial bridging procedures in treatment of acute liver failure.
    Boudjema K; Bachellier P; Wolf P; Tempé JD; Jaeck D
    World J Surg; 2002 Feb; 26(2):264-74. PubMed ID: 11865358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver progenitor cell line HepaRG differentiated in a bioartificial liver effectively supplies liver support to rats with acute liver failure.
    Nibourg GA; Chamuleau RA; van der Hoeven TV; Maas MA; Ruiter AF; Lamers WH; Oude Elferink RP; van Gulik TM; Hoekstra R
    PLoS One; 2012; 7(6):e38778. PubMed ID: 22719943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic liver support: optimal cell source and mass.
    Morsiani E; Brogli M; Galavotti D; Pazzi P; Puviani AC; Azzena GF
    Int J Artif Organs; 2002 Oct; 25(10):985-93. PubMed ID: 12456040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The optimal hepatocyte density for a hollow-fiber bioartificial liver.
    Xu Q; Sun X; Qiu Y; Zhang H; Ding Y
    Ann Clin Lab Sci; 2004; 34(1):87-93. PubMed ID: 15038673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.